How has been the historical performance of Fermenta Biotec.?

Answer:The historical performance of Fermenta Biotec shows significant fluctuations in its financial metrics over the years, with a notable recovery in the latest fiscal year.

Breakdown:
Fermenta Biotec's net sales increased from 335.66 Cr in Mar'24 to 469.48 Cr in Mar'25, marking a substantial growth. Total operating income followed a similar trend, rising to 469.48 Cr from 335.66 Cr. However, total expenditure also increased, reaching 359.68 Cr in Mar'25 from 308.15 Cr in the previous year. Operating profit, excluding other income, saw a remarkable rise to 109.80 Cr in Mar'25, compared to 27.51 Cr in Mar'24. This led to an operating profit margin of 23.39% in Mar'25, up from 8.2% in Mar'24. Profit before tax turned positive at 83.21 Cr in Mar'25, recovering from a loss of 9.87 Cr in Mar'24, and profit after tax also improved significantly to 76.40 Cr from a loss of 24.01 Cr. The consolidated net profit for Mar'25 was reported at 76.86 Cr, a recovery from a loss of 23.06 Cr in the previous year. In terms of assets, total assets decreased slightly to 585.83 Cr in Mar'25 from 525.83 Cr in Mar'24, while total liabilities also saw a decrease to 585.83 Cr from 525.83 Cr. Cash flow from operating activities was 40.00 Cr in Mar'25, down from 105.00 Cr in Mar'24, leading to a net cash outflow of 10.00 Cr in Mar'25. Overall, the financial performance indicates a recovery trajectory for Fermenta Biotec in the latest fiscal year.